Breaking News Instant updates and real-time market news.

MNTA

Momenta

$11.77

0.17 (1.47%)

, TEVA

Teva

$45.04

-0.02 (-0.04%)

05:45
10/11/16
10/11
05:45
10/11/16
05:45

Momenta upgraded to Overweight from Equal Weight at Barclays

Barclays analyst Douglas Tsao upgraded Momenta Pharmaceuticals to Overweight after attending the consolidated Copaxone 40mg trial. The analyst sees low risk of Momenta being blocked from the 40mg opportunity past 2018 and views the stock's risk/reward as "compelling" at current levels. Tsao believes there is a "good likelihood" that Sandoz, Momenta's partner, launches Copaxone 40mg at-risk as soon as February 2017 upon FDA approval when the 30-month stay expires. The analyst raised his price target for Momenta shares to $19 from $13.

MNTA

Momenta

$11.77

0.17 (1.47%)

TEVA

Teva

$45.04

-0.02 (-0.04%)

  • 13

    Oct

  • 14

    Oct

  • 06

    Nov

  • 15

    Nov

MNTA Momenta
$11.77

0.17 (1.47%)

09/07/16
MAXM
09/07/16
DOWNGRADE
MAXM
Sell
Momenta downgraded to Sell from Hold at Maxim
09/02/16
LEER
09/02/16
NO CHANGE
LEER
Outperform
Teva third Copaxone patent invalidated as expected, says Leerink
Leerink analyst Jason Gerberry says Teva (TEVA) suffered a largely expected loss in its Copaxone 40mg patent battle, with the Patent Trial and Appeal Board, or PTAB, ruling a third patent invalid. The analyst believes the company will likely appeal the loss, along with PTAB rulings rendered last week that other Copaxone patents were invalid. Gerberry sees the bull case scenario of Teva securing patent exclusivity of the Copaxone 40mg as unlikely and says a settlement with Momenta (MNTA) and Novartis (NVS) is the most logical course of action to mitigate 2017-2018E EPS risk. He reiterates an Outperform rating on Teva's shares.
08/31/16
LEER
08/31/16
NO CHANGE
Target $61
LEER
Outperform
Teva price target lowered to $61 from $66 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Teva (TEVA) to $61 from $66 on loss of Copaxone patent challenge as an upside catalyst. The analyst believes Teva's share price implies a generic entrant sometime in the second half of 2017 after losing an Inter Partes Review decision on two Copaxone 40mg anchor patents. In order to mitigate EPS downside in 2017-2018 and eliminate business uncertainty, Gerberry thinks the company should settle its Copaxone patent dispute with Novartis (NVS) and Momenta (MNTA), which he sees as "the most credible" generic threat. The analyst reiterates an Outperform rating on Teva's shares.
08/25/16
JPMS
08/25/16
NO CHANGE
JPMS
Overweight
Invalidation of Copaxone patents a 'clear positive' for Momenta, says JPMorgan
JPMorgan analyst Chris Schott said the USPTO invalidating two Copaxone 40mg patents is the first step towards a potential 2017 or 2018 generic launch and a "clear positive" for Momenta (MNTA), which he views as the most likely near-term generic threat to the 40mg dose of the drug. For patent holder Teva (TEVA), however, he does not see this as a meaningful setback, noting that his estimates already reflected expectations for competition in 2017. The firm has Overweight ratings on both Momenta and Teva shares.
TEVA Teva
$45.04

-0.02 (-0.04%)

10/07/16
LEER
10/07/16
NO CHANGE
Target $57
LEER
Outperform
Teva price target lowered to $57 from $61 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Teva to $57 from $61 and trimmed his estimates to reflect near-term headwinds and a more conservative Copaxone outlook. The analyst continues to view a generic Copaxone launch in late the second half of 2017 as a risk. Nonetheless, Gerberry reiterates an Outperform rating on the stock as he views shares as attractively valued despite near-term EPS concerns and believes investor attention will eventually pivot to Teva's attractive late stage pipeline.
10/06/16
WELS
10/06/16
NO CHANGE
WELS
Wells calls Teva partnership with Celltrion 'good news'
Wells Fargo analyst David Maris views Teva Pharmaceutical's partnership to commercialize two of Celltrion's monoclonal antibody biosimilar candidates as "good news." Teva is now a "little more firmly in the biosimilar game," Maris tells investors in a research note. He likes that the initial cash outflow is small and the partner. Maris has an Outperform rating on Teva.
10/05/16
WELS
10/05/16
NO CHANGE
WELS
Outperform
Teva estimates lowered on generic trends at Wells Fargo
Wells Fargo analyst David Maris lowered his estimates for Teva (TEVA) for this year and next, citing expectations for lower generic sales this year and lower margins in the generic business. Maris lowered his price target range for Teva shares to $60-$61 from $70-73 based on his lower estimates as well as the uncertainty of the environment, but keeps an Outperform rating on shares citing valuation and his belief 2017 should be a better year with several pipeline events for Teva.
10/03/16
WELS
10/03/16
NO CHANGE
WELS
Outperform
Teva shares suffering from lack of catalysts, says Wells Fargo
Wells Fargo analyst David Maris attributes the continued slide in Teva (TEVA) shares largely to negative sector news such as the drug pricing debate, fears on generic pricing, and Mylan's (MYL) EpiPen issue, but also thinks the slide has been made worse by Teva's lack of near-term catalysts. Additionally, the ongoing Copaxone generic trial and Teva's recently filed suit against Rimsa's founders over allegedly being misled by the Mexican pharmaceutical company have added to the pressure, Maris noted. Maris acknowledges there may be "no notable catalysts" for the rest of the year for Teva, but he thinks it should be a "robust 2017" for the company and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

QCOM

Qualcomm

$57.22

0.08 (0.14%)

03:55
02/27/17
02/27
03:55
02/27/17
03:55
Conference/Events
Qualcomm to hold an investor session at Mobile World Congress 2017 »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 13

    Mar

03:05
02/27/17
02/27
03:05
02/27/17
03:05
General news
FX Update: The yen has seen a safe haven bid »

FX Update: The yen has…

ERIC

Ericsson

$6.45

-0.08 (-1.23%)

01:55
02/27/17
02/27
01:55
02/27/17
01:55
Conference/Events
Ericsson to hold a media and analyst briefing at Mobile World Congress 2017 »

Media & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 29

    Mar

SSNLF

Samsung

, T

AT&T

$42.36

0.41 (0.98%)

22:24
02/26/17
02/26
22:24
02/26/17
22:24
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SSNLF

Samsung

T

AT&T

$42.36

0.41 (0.98%)

QCOM

Qualcomm

$57.22

0.08 (0.14%)

INTC

Intel

$36.53

0.35 (0.97%)

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

DBOEY

Deutsche Boerse

$8.60

-0.045 (-0.52%)

CMCSA

Comcast

$37.89

0.24 (0.64%)

CMCSK

Comcast

LGF.A

Lionsgate

$27.18

-0.08 (-0.29%)

LGF.B

Lionsgate

$25.16

-0.19 (-0.75%)

TV

Grupo Televisa

$26.44

0.69 (2.68%)

RIG

Transocean

$13.75

-0.56 (-3.91%)

GPN

Global Payments

$78.97

0.76 (0.97%)

AXTA

Axalta Coating

$29.38

-0.09 (-0.31%)

SNAP

Snap Inc.

HOG

Harley-Davidson

$56.56

-1.12 (-1.94%)

SAM

Boston Beer

$159.20

1.3 (0.82%)

STX

Seagate

$47.75

0.36 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 13

    Mar

  • 19

    Mar

  • 28

    Mar

  • 04

    Apr

  • 05

    Apr

  • 02

    Mar

NOK

Nokia

$5.14

-0.01 (-0.19%)

, VZ

Verizon

$50.60

0.29 (0.58%)

21:19
02/26/17
02/26
21:19
02/26/17
21:19
Hot Stocks
Nokia CEO: 'Noise' about carrier M&A to heat up in 2017 »

Speaking at a press event…

NOK

Nokia

$5.14

-0.01 (-0.19%)

VZ

Verizon

$50.60

0.29 (0.58%)

T

AT&T

$42.36

0.41 (0.98%)

TMUS

T-Mobile

$62.21

0.14 (0.23%)

S

Sprint

$8.94

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 23

    May

SNE

Sony

$30.93

-0.31 (-0.99%)

20:43
02/26/17
02/26
20:43
02/26/17
20:43
Hot Stocks
Sony confirms 915,000 PlayStation VR global unit sales »

Sony Interactive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 10

    Mar

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

, BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

20:38
02/26/17
02/26
20:38
02/26/17
20:38
Hot Stocks
Berkshire Hathaway says paid roughly $110.17 per share for Apple stake »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

AAPL

Apple

$136.66

0.13 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 13

    Mar

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

, BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

20:31
02/26/17
02/26
20:31
02/26/17
20:31
Hot Stocks
Buffett: Will be 'ready to act' on share repurchase opportunities »

Writing in Berkshire…

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

20:25
02/26/17
02/26
20:25
02/26/17
20:25
Hot Stocks
Samsung teases March 29 date for next Galaxy device »

Samsung has issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    Mar

SNE

Sony

$30.93

-0.31 (-0.99%)

20:14
02/26/17
02/26
20:14
02/26/17
20:14
Periodicals
Sony sells 915,000 Playstation VR units in first four months, NYT says »

Speaking in a New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 10

    Mar

AAPL

Apple

$136.66

0.13 (0.10%)

20:07
02/26/17
02/26
20:07
02/26/17
20:07
Hot Stocks
Al Gore sells 215,400 shares of Apple »

Apple board member and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 13

    Mar

BBRY

BlackBerry

$7.08

-0.08 (-1.12%)

20:00
02/26/17
02/26
20:00
02/26/17
20:00
Hot Stocks
TCL Communication unveils 'BlackBerry KEYone' smartphone »

Smartphone manufacturer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$153.48

0.19 (0.12%)

, GD

General Dynamics

$189.63

1.33 (0.71%)

19:57
02/26/17
02/26
19:57
02/26/17
19:57
Periodicals
Trump to seek 'sharp' boost in defense spending, NYT says »

President Donald Trump…

RTN

Raytheon

$153.48

0.19 (0.12%)

GD

General Dynamics

$189.63

1.33 (0.71%)

LMT

Lockheed Martin

$266.00

1.15 (0.43%)

BA

Boeing

$177.44

0.58 (0.33%)

UTX

United Technologies

$112.46

0.37 (0.33%)

NOC

Northrop Grumman

$245.05

1.19 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMAX

IMAX

$32.75

1.6 (5.14%)

19:52
02/26/17
02/26
19:52
02/26/17
19:52
Hot Stocks
IMAX says China's Bona Film commits to 30 new IMAX theatres »

IMAX and IMAX China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 28

    Mar

  • 28

    Mar

F

Ford

$12.47

-0.09 (-0.72%)

, GM

General Motors

$36.90

-0.35 (-0.94%)

19:49
02/26/17
02/26
19:49
02/26/17
19:49
Periodicals
Chao says Trump administration reviewing autonomous car guidance, Reuters says »

Transportation Secretary…

F

Ford

$12.47

-0.09 (-0.72%)

GM

General Motors

$36.90

-0.35 (-0.94%)

TSLA

Tesla

$257.00

1.01 (0.39%)

GOOG

Alphabet

$828.64

-2.69 (-0.32%)

GOOGL

Alphabet Class A

$847.81

-3.19 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 19

    Mar

INVH

Invitation Homes

$21.60

0.02 (0.09%)

19:35
02/26/17
02/26
19:35
02/26/17
19:35
Initiation
Invitation Homes initiated  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$75.88

-1 (-1.30%)

19:24
02/26/17
02/26
19:24
02/26/17
19:24
Periodicals
SoftBank poised to invest over $3B in WeWork, CNBC says »

SoftBank is nearing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPN

Groupon

$4.47

0.05 (1.13%)

19:22
02/26/17
02/26
19:22
02/26/17
19:22
Recommendations
Groupon analyst commentary  »

Piper believes Groupon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

ALSN

Allison Transmission

$36.79

0.24 (0.66%)

, F

Ford

$12.47

-0.09 (-0.72%)

19:07
02/26/17
02/26
19:07
02/26/17
19:07
Downgrade
Allison Transmission, Ford rating change  »

Allison Transmission…

ALSN

Allison Transmission

$36.79

0.24 (0.66%)

F

Ford

$12.47

-0.09 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 11

    May

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

, BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

18:39
02/26/17
02/26
18:39
02/26/17
18:39
Hot Stocks
Berkshire Hathaway's Buffett: Expect normalized earning power to grow every year »

Writing in Berkshire…

BRK.A

Berkshire Hathaway

$255,040.00

140 (0.05%)

BRK.B

Berkshire Hathaway

$170.22

0.07 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBOEY

Deutsche Boerse

$8.60

-0.045 (-0.52%)

18:26
02/26/17
02/26
18:26
02/26/17
18:26
Hot Stocks
Deutsche Boerse sees European Commission merger decision by end of March »

Deutsche Boerse issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MESO

Mesoblast

$6.40

-0.14 (-2.14%)

18:23
02/26/17
02/26
18:23
02/26/17
18:23
Hot Stocks
Mesoblast outlines expected 2017 milestones »

Mesoblast stated that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Apr

LIOX

Lionbridge

16:58
02/26/17
02/26
16:58
02/26/17
16:58
Conference/Events
Lionbridge to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.89

0.24 (0.64%)

, CMCSK

Comcast

16:54
02/26/17
02/26
16:54
02/26/17
16:54
Hot Stocks
Box Office Battle: Comedy horror 'Get Out' thrills in $31M opening »

Comcast's (CMCSA)…

CMCSA

Comcast

$37.89

0.24 (0.64%)

CMCSK

Comcast

TWX

Time Warner

$97.28

0.6225 (0.64%)

LGF.A

Lionsgate

$27.18

-0.08 (-0.29%)

LGF.B

Lionsgate

$25.16

-0.19 (-0.75%)

DIS

Disney

$110.32

0.59 (0.54%)

FOX

21st Century Fox

$30.23

0.23 (0.77%)

FOXA

21st Century Fox

$30.61

0.27 (0.89%)

VIA

Viacom

VIAB

Viacom

$43.89

0.03 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

WAT

Waters

$156.40

1.51 (0.97%)

16:38
02/26/17
02/26
16:38
02/26/17
16:38
Conference/Events
Waters to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 01

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.